Presentation TCT 2012 Extravascular Renal Denervation (Ablative Solutions) Presenter: Tim Fischell October 24, 2012
Presentation TCT 2012 What's Known and Not Known About Renal Denervation for Hypertension: Critical Appraisal of the Clinical Data Presenter: Deepak Bhatt October 24, 2012
Presentation TCT 2012 Translational Medicine and Renal Denervation: Preclinical Animal Models and Histoanatomy Presenter: Renu Virmani October 24, 2012
Presentation TCT 2012 Renal Sympathetic Denervation as the "Ideal Target" for Refractory Hypertension: Anatomy and Pathophysiology Presenter: Michael Bohm October 24, 2012
Presentation TCT 2012 Measuring the Clinical Effects of Renal Denervation: Are Office Blood Pressure and 24-Hour Ambulatory Blood Pressure Monitoring the Best Surrogates? Presenter: Paul Sobotka October 24, 2012
Presentation TCT 2012 Catheter-Based Technology Alternatives for Renal Denervation Presenter: Horst Sievert October 24, 2012
Presentation TCT 2012 Beyond Hypertension: Future Prospects for Renal Denervation Therapy Presenter: Paul Sobotka October 24, 2012
Presentation TCT 2012 TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model Presenter: Michael Joner October 23, 2012
Presentation TCT 2012 TCT-14. Effects of Renal Sympathetic Denervation on Heart Rate and Atrioventricular Conduction in Patients with Resistant Hypertension Presenter: Christian Ukena October 23, 2012
Presentation TCT 2012 TCT-13. Renal Resistive Indices, Urinary Albumin Excretion and Renal Function in Patients with Resistant Hypertension After Catheter-based Renal Sympathetic Denervation Presenter: Felix Mahfoud October 23, 2012
Presentation TCT 2012 TCT-12. Long-term Follow-up of Catheter-based Renal Denervation for Resistant Hypertension Confirms Durable Blood Pressure Reduction Presenter: Markus Schlaich October 23, 2012
Presentation TCT 2012 TCT-11. Renal Sympathetic Denervation - Inducing an Instantaneous and Persisting 24h Ambulatory Blood Pressure Drop in Patients With Resistant Hypertension – Results from the... Presenter: Alexander Plehn October 23, 2012
Presentation TCT 2012 TCT-10. Efficacy of Renal Denervation is Positively Impacted by Longitudinal Treatments Presenter: Meital Mazor October 23, 2012
Presentation TCT 2012 Renal Sympathetic Denervation for HTN Presenter: Lynne Hinterbuchner October 22, 2012
News Industry News Vessix Vascular to Present 3-Month, 6-Month Results From REDUCE-HTN Renal Denervation Clinical Study at TCT October 22, 2012
News Industry News Two-Year Follow-Up Of Symplicity Htn-1 Data Confirms Significant And Sustained Blood Pressure Reduction In Expanded Cohort Of Patients October 22, 2012
News Industry News Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference October 18, 2012
News Industry News Medtronic Completes First-In-Man Study for Investigational Next-Generation Multi-Electrode Renal Denervation System in Patients with Treatment-Resistant Hypertension October 03, 2012